Skip to main content

Lisata Therapeutics, Inc.

LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000320017

No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.

Members of Congress who traded LSTA

No member of Congress has reported a trade in Lisata Therapeutics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.